Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Online Risk Calculator for Knee OA Influences Patient Risk Perception

Arthritis Care & Research  |  August 1, 2017

Disease-modifying drugs are not currently available for treating knee osteoarthritis (OA); therefore, prevention strategies focus on patient risk factors, such as obesity and injury, for reducing the burden of disease. Understanding their personal risk factors may influence patients’ OA prevention efforts.

To measure patients’ perception of their own risk of developing knee OA, Elena Losina, PhD, and colleagues from Brigham and Women’s Hospital and Harvard Medical School, Boston, developed a personalized risk calculator that uses demographic and risk factor information to estimate knee OA risk. In a recent study, published in the August 2017 issue of Arthritis Care & Research, researchers tested the efficacy of the calculator on that accuracy of risk perception. Researchers also used contemplation ladders to measure a patient’s willingness to implement behavior changes that would prevent weight gain, such as increase exercise, improve diet and control weight—all established risk factors for knee OA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The study included 375 participants, recruited through the Amazon Mechanical Turk, who were randomized to use the personalized risk calculator, OA Risk C, or receive general OA risk information (control group). Subjects estimated their 10-year and lifetime risk and responded to contemplation ladders at baseline and after the interventions. At baseline, the mean age of participants was 32 years old with a mean body mass index of 27. Subjects in both study arms had an average 3.6% chance of developing symptomatic knee OA in the next 10 years and a 25.3% chance of developing knee OA in their lifetime.

The Results
“Prior to the intervention, both groups highly overestimated their risk of developing knee OA in 10 years and over the course of their lifetime,” write the authors. “Use of the personalized risk calculator facilitated more accurate perception of knee OA risk.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For the intervention group, the perceived 10-year risk decreased by 12.9% (95% confidence interval [CI] 215.7, 210.1)—from 25.4% (95% CI 22.0, 28.8) to 12.5% (95% CI 10.0, 15.0)—and perceived lifetime risk decreased by 19.5 % (95% CI 222.9, 216.0) to 28.1% (95% CI 25.2, 31.0). However, participants in the control group did not report change in their risk perception. Their perceived 10-year risk increased by 0.8% and their perceived lifetime risk decreased by 0.9%.

Additionally, the study found that participants in the intervention group were more likely to move to an action stage on the exercise contemplation ladder: 26.9% of risk calculator subjects moved into an exercise action stage, compared with 13.6% of control subjects (relative risk 2.1 [95% CI 0.9, 4.7]). However, the authors note, “For [the] weight control and diet contemplation ladders, the data did not suggest that the intervention increased subjects’ willingness to move to an action stage (RR 1.0 and 1.3, respectively).”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis Care & ResearchkneeKnee Osteoarthritis (OA)patient educationrisk

Related Articles

    Exercise Therapy Recommended to Manage Knee Osteoarthritis

    July 12, 2016

    The benefits of exercise therapy for individuals with knee osteoarthritis (OA) are well known. The ACR strongly recommends both aquatic exercise and land-based aerobic and resistance exercise for managing knee OA.1 A recent Cochrane systematic review and meta-analysis concluded that high-quality evidence supports the use of exercise to reduce pain and improve physical function and…

    Is Rheumatoid Arthritis Preventable?

    December 18, 2017

    Is rheumatoid arthritis (RA) preventable? Results of a newly published study suggest that personalized medicine approaches may result in health behavior that may reduce RA risk. “We have gotten to the point where we’ve identified some modifiable behaviors that affect rheumatoid arthritis risk,” says Jeffrey A. Sparks, MD, MMSc, assistant professor of medicine in the…

    Exercises to Improve Outcomes in Knee Osteroarthritis

    May 1, 2008

    An exercise program can improve functionality and quality of life

    Physical Activity, Exercise Can Benefit Patients with RA

    November 9, 2017

    While medical advances in rheumatoid arthritis (RA) have led to improvements in disease control and quality of life for patients worldwide, the rate for stable remission remains low.1 Management of RA symptoms is traditionally accomplished through a combination of medications and nonpharmacological interventions.2 This approach can prevent the development of secondary adverse health outcomes. Two…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences